Biotech startup raises $64 million to erase cancer — it’s even in the name

San Diego startup Erasca said Tuesday it has raised $64 million to develop cancer therapies with the ambitious goal of eventually curing the disease.

The new funding is up from the $42 million reported in December.

New investors in privately held Erasca include ARCH Venture Partners; Andreessen…